NCT05704894 2023-01-30
Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens
Blau Farmaceutica S.A.
Phase 3 Unknown
Blau Farmaceutica S.A.
Second Affiliated Hospital, School of Medicine, Zhejiang University
University College, London
National Cancer Institute (NCI)
Instituto do Cancer do Estado de São Paulo